Search results
1 company and 6 research reports found for "Sosei Group Corporation"
Company results
- Sosei Group Corporation
Sosei Group Corporation is a Japan-based biopharma focused on R&D and drug re-profiling. It is activ...
Sector reports
No sector reports have been found.
Research results
Sosei Group Corporation
Business developments
Update | Pharmaceutical & Healthcare | 19/05/2011Sosei has secured two new deals, each with the potential to broaden its pipeline and address the Japanese ‘drug lag’. It has licensed Japan rights...
Sosei Group Corporation
Launch and data nearing
Outlook | Pharmaceutical & Healthcare | 01/03/20112011 should prove to be a transformative year for Sosei, with the upcoming Japan launch of its emergency contraceptive, NorLevo (SOH-075), and Phase I...
Sosei Group Corporation
Formulating value
Review | Pharmaceutical & Healthcare | 17/11/2010Partner Novartis has confirmed that key value drivers NVA237 and QVA149 are on track to meet market expectations for launch (2012 and 2013 respectivel...
Sosei Group Corporation
New technology platform
Update | Pharmaceutical & Healthcare | 30/06/2010Sosei is to acquire the privately-held Japanese biopharmaceutical company Activus Pharma, for c ¥500m ($5.5m) in cash. Activus has a nanoparticle dru...
Sosei Group Corporation
Milestone boosts cash
Update | Pharmaceutical & Healthcare | 26/05/2010Sosei’s investment case is reliant on the successful development of COPD therapies NVA237 and QVA149, jointly licensed to Novartis with Vectura. Key...
Sosei Group Corporation
A purer play on COPD?
Outlook | Pharmaceutical & Healthcare | 03/03/2010Sosei’s investment case is highly reliant on the successful development of COPD therapies NVA237 and QVA149, jointly licensed to Novartis with Vectu...
